Vanguard Group’s Corbus Pharmaceuticals CRBP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.14M | Sell |
599,495
-72,562
| -11% | -$501K | ﹤0.01% | 3273 |
|
|
2025
Q1 | $3.57M | Buy |
672,057
+12,855
| +2% | +$68.3K | ﹤0.01% | 3292 |
|
|
2024
Q4 | $7.78M | Buy |
659,202
+13,552
| +2% | +$160K | ﹤0.01% | 3075 |
|
|
2024
Q3 | $13.3M | Buy |
645,650
+60,661
| +10% | +$1.25M | ﹤0.01% | 2812 |
|
|
2024
Q2 | $26.5M | Buy |
584,989
+147,725
| +34% | +$6.68M | ﹤0.01% | 2433 |
|
|
2024
Q1 | $17.2M | Buy |
437,264
+257,808
| +144% | +$10.1M | ﹤0.01% | 2677 |
|
|
2023
Q4 | $1.08M | Hold |
179,456
| – | – | ﹤0.01% | 3799 |
|
|
2023
Q3 | $1.21M | Hold |
179,456
| – | – | ﹤0.01% | 3763 |
|
|
2023
Q2 | $1.41M | Buy |
179,456
+1
| +0% | +$8 | ﹤0.01% | 3789 |
|
|
2023
Q1 | $1.3M | Sell |
179,455
-3,869,647
| -96% | -$28.1M | ﹤0.01% | 3833 |
|
|
2022
Q4 | $447K | Buy |
4,049,102
+2,347
| +0.1% | +$259 | ﹤0.01% | 4123 |
|
|
2022
Q3 | $668K | Sell |
4,046,755
-245,408
| -6% | -$40.5K | ﹤0.01% | 4134 |
|
|
2022
Q2 | $1.08M | Hold |
4,292,163
| – | – | ﹤0.01% | 4062 |
|
|
2022
Q1 | $2.28M | Sell |
4,292,163
-1,112,097
| -21% | -$591K | ﹤0.01% | 3903 |
|
|
2021
Q4 | $3.33M | Sell |
5,404,260
-62,581
| -1% | -$38.5K | ﹤0.01% | 3827 |
|
|
2021
Q3 | $5.58M | Buy |
5,466,841
+4,791
| +0.1% | +$4.89K | ﹤0.01% | 3588 |
|
|
2021
Q2 | $10M | Buy |
5,462,050
+1,658,273
| +44% | +$3.03M | ﹤0.01% | 3201 |
|
|
2021
Q1 | $7.49M | Buy |
3,803,777
+91,925
| +2% | +$181K | ﹤0.01% | 3318 |
|
|
2020
Q4 | $4.64M | Sell |
3,711,852
-410,021
| -10% | -$513K | ﹤0.01% | 3393 |
|
|
2020
Q3 | $7.42M | Buy |
4,121,873
+551,675
| +15% | +$993K | ﹤0.01% | 2946 |
|
|
2020
Q2 | $30M | Buy |
3,570,198
+15,096
| +0.4% | +$127K | ﹤0.01% | 2238 |
|
|
2020
Q1 | $18.6M | Buy |
3,555,102
+334,005
| +10% | +$1.75M | ﹤0.01% | 2322 |
|
|
2019
Q4 | $17.6M | Buy |
3,221,097
+79,796
| +3% | +$436K | ﹤0.01% | 2592 |
|
|
2019
Q3 | $15.3M | Buy |
3,141,301
+61,135
| +2% | +$298K | ﹤0.01% | 2602 |
|
|
2019
Q2 | $21.3M | Buy |
3,080,166
+220,625
| +8% | +$1.53M | ﹤0.01% | 2480 |
|
|
2019
Q1 | $19.9M | Buy |
2,859,541
+387,708
| +16% | +$2.69M | ﹤0.01% | 2508 |
|
|
2018
Q4 | $14.4M | Buy |
2,471,833
+81,819
| +3% | +$478K | ﹤0.01% | 2594 |
|
|
2018
Q3 | $18M | Buy |
2,390,014
+11,609
| +0.5% | +$87.7K | ﹤0.01% | 2627 |
|
|
2018
Q2 | $12M | Buy |
2,378,405
+217,096
| +10% | +$1.1M | ﹤0.01% | 2810 |
|
|
2018
Q1 | $13.2M | Buy |
2,161,309
+19,156
| +0.9% | +$117K | ﹤0.01% | 2680 |
|
|
2017
Q4 | $15.2M | Buy |
2,142,153
+418,733
| +24% | +$2.97M | ﹤0.01% | 2618 |
|
|
2017
Q3 | $12.3M | Buy |
1,723,420
+160,012
| +10% | +$1.14M | ﹤0.01% | 2711 |
|
|
2017
Q2 | $9.85M | Buy |
1,563,408
+307,979
| +25% | +$1.94M | ﹤0.01% | 2780 |
|
|
2017
Q1 | $10.4M | Buy |
1,255,429
+71,419
| +6% | +$589K | ﹤0.01% | 2751 |
|
|
2016
Q4 | $10M | Sell |
1,184,010
-6,496
| -0.5% | -$54.9K | ﹤0.01% | 2743 |
|
|
2016
Q3 | $8.08M | Buy |
1,190,506
+535,605
| +82% | +$3.64M | ﹤0.01% | 2791 |
|
|
2016
Q2 | $1.96M | Buy |
654,901
+169,322
| +35% | +$506K | ﹤0.01% | 3393 |
|
|
2016
Q1 | $879K | Buy |
485,579
+44,420
| +10% | +$80.4K | ﹤0.01% | 3633 |
|
|
2015
Q4 | $728K | Buy |
441,159
+16,410
| +4% | +$27.1K | ﹤0.01% | 3722 |
|
|
2015
Q3 | $667K | Buy |
424,749
+91,036
| +27% | +$143K | ﹤0.01% | 3759 |
|
|
2015
Q2 | $1.03M | Buy |
+333,713
| New | +$1.03M | ﹤0.01% | 3656 |
|